This underscores the necessity of CML cells subjected to energy restriction to undertake a process leading to BCR/Abl protein suppression regardless of the molecular mechanisms involved. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.